Corporate news

Mölnlycke to establish R&D innovation unit in AstraZeneca’s BioVentureHub

By: Mölnlycke Health Care, June 2 2017Posted in: Corporate news

The new unit will build on Mölnlycke’s cell biology and analytical chemistry capabilities, and develop innovative advanced wound care and surgical solutions along the entire continuum of care – from prevention to post-acute settings.

`We are very excited to be part of AstraZeneca’s BioVentureHub, as it offers a unique opportunity for us to collaborate with AstraZeneca’s world-class scientists and benefit from their state-of-the-art facilities and infrastructure while developing new advanced wound care and surgical solutions for our customers. We’re also looking forward to exploring collaboration opportunities with the other BioVentureHub companies,´ comments Richard Twomey, CEO of Mölnlycke.

Magnus Björsne, CEO for AstraZeneca’s BioVentureHub, says, `It’s fantastic that a well-established, global, medical solutions company like Mölnlycke wants to be part of our innovation experiment. Besides further strengthening the life science ecosystem in West Sweden, this collaboration offers new opportunities to work with innovation across different value chains. AstraZeneca is continuously looking for new ways to deliver drugs to the right place in the body. Preventing pressure ulcers and infections related to diabetes and metabolic diseases is just one area where we could collaborate more closely to benefit patients.´

The agreement was signed by Barry McBride, Executive Vice-President for R&D at Mölnlycke, and Jan-Olof Jacke, President of AstraZeneca Sweden, during the AstraZeneca Exchange 2017 event. 

About AstraZeneca's BioVentureHub

AstraZeneca established the BioVentureHub in 2014 as an open innovation ecosystem to further strengthen competitiveness and dynamism in the Scandinavian life science industry. Based on an innovative public-private partnership model and located at the heart of AstraZeneca Gothenburg, the BioVenturehub gives emerging biotech/medtech companies and academic groups from Sweden and abroad a unique opportunity to co-locate with - and tap into - the power of AstraZeneca’s world-class scientists and state-of-the-art lab facilities and infrastructure, and with each other.

See www.azbioventurehub.com

Contact at AstraZeneca's BioVentureHub

Jamie Smith
AstraZeneca BioVentureHub
Jamie.Smith1@astrazeneca.com
+46 723-757507

About Mölnlycke

Mölnlycke is a world leading medical solutions company. Our purpose is to advance performance in healthcare across the world. That is why we aspire to equip everybody in healthcare with solutions to achieve the best outcomes. We develop and bring to market innovative wound care and surgical solutions along the entire continuum of care – from prevention to post-acute settings. Our solutions provide value for money, supported by clinical and health economic evidence. Mölnlycke was founded in 1849. Nowadays, our solutions are available in around 100 countries; we are the number one global provider of advanced wound care and single-use surgical products; and we are Europe’s largest provider of customized trays. Our headquarters are in Gothenburg, Sweden and we have about 7,500 employees around the world.

Learn more at www.molnlycke.com

Contact

Bodil Czarnecki Mölnlycke Health Care AB
Bodil.Czarnecki@molnlycke.com
+46 31 722 30 37

Share this

More from the same category

Facing Africa

“There are people who make faces like clothes - They build my face just like God… "I will never...

360 Magazine 2014/2015 edition

At Mölnlycke Health Care, we are passionate about serving our customers...

Proud to get Blisters in aid of DebRA!

On Saturday 25th October our UK Communications Team, Lucy, Vicky, Anna...

Facing Africa – Heather’s Diary Facing...

Every year, Mölnlycke Health Care sponsor the charity Facing Africa by...

Facing Africa – Heather’s Diary Part...

Once we have all eaten, we get into the mini buses and travel 40 minutes...

Facing Africa - Heather's Diary Part...

I am woken up at 4am by prayers over a tannoy. These are located at churches...

Facing Africa – Heather’s Diary Part...

Monday 6th October: I wake up to beautiful sunshine, the roads are dry...

Facing Africa – Heather’s Diary Part...

Tuesday 7th October: My last day in Ethiopia. We arrive on the ward to...

Mölnlycke to divest Dry Tips®

Mölnlycke Health Care has reached an agreement to divest the dental product Dry...

Statement concerning medical devices...

Mölnlycke Health Care product ranges are predominantly* designed and regulated...

Mölnlycke Health Care Proud to Support...

Mölnlycke Health Care are delighted to have been able to offer our support...

Ensuring compliance with the NHS eProcurement...

You may have heard a lot recently in the healthcare environment about the...

Company magazine and sustainability...

The 2015 Mölnlycke Health Care Magazine: Sustainable Business, Sustainable...

We are moving! Dunstable to Milton Keynes

We would like to inform you of a change in location for one of our UK offices...